News

The New Foreign Corrupt Practices Act Initiative to Target Violations by Pharmaceutical and Device Manufacturers

November 2009

Pharmaceutical Congress, Washington, DC,

Meet the Speakers

Kirk Ogrosky
Partner
Arnold & Porter
Subscribe
Subscribe Link

Email Disclaimer